Zobrazeno 1 - 10
of 507
pro vyhledávání: '"T. Tanoue"'
Autor:
Frank C. Detterbeck, Ulas Kumbasar, Andrew X. Li, Ami N. Rubinowitz, Leah Traube, Babina Gosangi, Brooks V. Udelsman, Brett C. Bade, Sora Ely, Gaspar Barreto, Lynn T. Tanoue, Edith M. Marom, M. Patricia Rivera
Publikováno v:
Journal of Thoracic Disease. 15:731-746
Autor:
Lynn T. Tanoue, Laura Evans
Publikováno v:
Chest. 163:1020-1022
Publikováno v:
Blood Pressure, Vol 26, Iss 2, Pp 94-101 (2017)
Background: Abnormal P-wave terminal force in lead V1 (PTF-V1) is an ECG marker of increased left atrial (LA) volume, elevated LA filling pressures and/or LA systolic dysfunction. Because left ventricular (LV) diastolic dysfunction is one of the pote
Externí odkaz:
https://doaj.org/article/86f8ea989bdc43e59b147b3b9c3d2d6e
Autor:
Frederick H. Wilson, Roy S. Herbst, Kurt A. Schalper, Bonnie E. Gould Rothberg, Lynn T. Tanoue, Viswanathan Muthusamy, Yulia V. Surovtseva, Laura Abriola, Yuping Qian, Man Li, Heather Lazowski, Dejian Zhao, Lisa Hunihan
Purpose:The identification of actionable oncogenic alterations has enabled targeted therapeutic strategies for subsets of patients with advanced malignancies, including lung adenocarcinoma (LUAD). We sought to assess the frequency of known drivers an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88bd2ceba73caea9de14ebd29e749e31
https://doi.org/10.1158/1078-0432.c.6532428.v1
https://doi.org/10.1158/1078-0432.c.6532428.v1
Autor:
Frederick H. Wilson, Roy S. Herbst, Kurt A. Schalper, Bonnie E. Gould Rothberg, Lynn T. Tanoue, Viswanathan Muthusamy, Yulia V. Surovtseva, Laura Abriola, Yuping Qian, Man Li, Heather Lazowski, Dejian Zhao, Lisa Hunihan
Supplementary Table from RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dd89822c5c2f2e906cb207bf4eeff63
https://doi.org/10.1158/1078-0432.22486953
https://doi.org/10.1158/1078-0432.22486953
Autor:
Frederick H. Wilson, Roy S. Herbst, Kurt A. Schalper, Bonnie E. Gould Rothberg, Lynn T. Tanoue, Viswanathan Muthusamy, Yulia V. Surovtseva, Laura Abriola, Yuping Qian, Man Li, Heather Lazowski, Dejian Zhao, Lisa Hunihan
Supplementary Data from RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33306144669c1f98612923c4a9499224
https://doi.org/10.1158/1078-0432.22486989.v1
https://doi.org/10.1158/1078-0432.22486989.v1
Autor:
Frederick H. Wilson, Roy S. Herbst, Kurt A. Schalper, Bonnie E. Gould Rothberg, Lynn T. Tanoue, Viswanathan Muthusamy, Yulia V. Surovtseva, Laura Abriola, Yuping Qian, Man Li, Heather Lazowski, Dejian Zhao, Lisa Hunihan
Supplementary Figure from RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::255d70f29bd11c0019051f3321015fc5
https://doi.org/10.1158/1078-0432.22486974.v1
https://doi.org/10.1158/1078-0432.22486974.v1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lisa Hunihan, Dejian Zhao, Heather Lazowski, Man Li, Yuping Qian, Laura Abriola, Yulia V. Surovtseva, Viswanathan Muthusamy, Lynn T. Tanoue, Bonnie E. Gould Rothberg, Kurt A. Schalper, Roy S. Herbst, Frederick H. Wilson
Publikováno v:
Clin Cancer Res
Purpose: The identification of actionable oncogenic alterations has enabled targeted therapeutic strategies for subsets of patients with advanced malignancies, including lung adenocarcinoma (LUAD). We sought to assess the frequency of known drivers a
Autor:
Brett C. Bade, Alexandria Brackett, Lori A. Bastian, Hilary C Cain, Craig G. Gunderson, Kathleen M. Akgün, Yukiko Kunitomo, Lynn T. Tanoue
Publikováno v:
Chest. 161:266-275
Background In 2013, the United States Preventive Services Taskforce instituted recommendations for annual lung cancer screening (LCS) with low-dose chest CT imaging for high-risk individuals. LCS reduces lung cancer mortality, with greater reduction